Peritoneal Permeability in Continuous Ambulatory Peritoneal Dialysis After the Correction of Anemia by Erythropoietin
作者： C. Castelnovo , A. De Vecchi , A. Scalamogna , S. Casati
DOI: 10.1007/978-3-642-77074-6_26
关键词: Erythropoietin 、 Hemodialysis 、 Continuous ambulatory peritoneal dialysis 、 Dialysis 、 In patient 、 Urology 、 Peritoneal permeability 、 Chronic renal failure 、 Anemia 、 Medicine
摘要: Anemia due to insufficient production of erythropoietin is a common feature patients with chronic renal failure undergoing dialysis [1-6]. Although anemia in on continuous ambulatory peritoneal (CAPD) less frequent and severe than hemodialysis (HD) [5] it can be relevant clinical problem [6].
springer.com
sci-hub.st 参考文章(5)
I. C. Macdougall, M. E. Davies, R. D. Hutton, I. Cavill, N. P. Lewis, G. A. Coles, J. D. Williams, The Treatment of Renal Anaemia in CAPD Patients with Recombinant Human Erythropoietin Nephrology Dialysis Transplantation. ,vol. 5, pp. 950- 955 ,(1990) , 10.1093/NDT/5.11.950
Claudio Ponticelli, Stefano Casati, Correction of anaemia with recombinant human erythropoietin. Nephron. ,vol. 52, pp. 201- 208 ,(1989) , 10.1159/000185643
H.B. Steinhauer, I. Lubrich-Birkner, K.W. Dreyling, W.H. Hörl, P. Schollmeyer, Increased Ultrafiltration after Erythropoietin-Induced Correction of Renal Anemia in Patients on Continuous Ambulatory Peritoneal Dialysis Nephron. ,vol. 53, pp. 91- 92 ,(1989) , 10.1159/000185716
S Casati, P Passerini, M R Campise, G Graziani, B Cesana, M Perisic, C Ponticelli, Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. BMJ. ,vol. 295, pp. 1017- 1020 ,(1987) , 10.1136/BMJ.295.6605.1017
B. Piraino, J. R. Johnston, The use of subcutaneous erythropoietin in CAPD patients Clinical Nephrology. ,vol. 33, pp. 200- 202 ,(1990)